Simeprevir and Sofosbuvir With Modified Doses of Ribavirin (RBV) Therapy on Telaprevir-Experienced, Coinfected (With HIV) Cirrhotics With Chronic Hepatitis C (CHC): A Randomized, Open-Label, Clinical Pilot Study, STOP C, Interim Results

Basu Patrick; Shah Niraj; Aloysius Mark

首页> 外文期刊>The American Journal of Gastroenterology >Simeprevir and Sofosbuvir With Modified Doses of Ribavirin (RBV) Therapy on Telaprevir-Experienced, Coinfected (With HIV) Cirrhotics With Chronic Hepatitis C (CHC): A Randomized, Open-Label, Clinical Pilot Study, STOP C, Interim Results

【24h】

Simeprevir and Sofosbuvir With Modified Doses of Ribavirin (RBV) Therapy on Telaprevir-Experienced, Coinfected (With HIV) Cirrhotics With Chronic Hepatitis C (CHC): A Randomized, Open-Label, Clinical Pilot Study, STOP C, Interim Results

机译：Simeprevir和Sofosbuvir改良剂量的利巴韦林（RBV）治疗特拉帕韦尔经验，合并感染（合并HIV）的慢性丙型肝炎（CHC）肝硬化药物：随机，开放标签，临床试验研究，STOP C，中期结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2014年第2期|共1页
作者
Basu Patrick; Shah Niraj; Aloysius Mark;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献

1. Simeprevir and Sofosbuvir With Modified Doses of Ribavirin (RBV) Therapy on Telaprevir-Experienced, Coinfected (With HIV) Cirrhotics With Chronic Hepatitis C (CHC): A Randomized, Open-Label, Clinical Pilot Study, STOP C, Interim Results [J] . Basu Patrick, Shah Niraj, Aloysius Mark The American Journal of Gastroenterology . 2014,第Suppla2期

机译：Simeprevir和Sofosbuvir改良剂量的利巴韦林（RBV）治疗特拉帕韦尔经验，合并感染（合并HIV）的慢性丙型肝炎（CHC）肝硬化药物：随机，开放标签，临床试验研究，STOP C，中期结果
2. Real-world Effectiveness (RWE) and Adverse Events with Sofosbuvir plus Ribavirin (SOF plus RBV) Based Therapies in Chronic Hepatitis C Genotype 3 (CHC GT 3) Patients in Asia-A Systematic Review of 8 Studies and 3510 Patient [J] . Wei Bin, Ji Fanpu, Yeo Yee Hui, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：亚洲慢性丙基肝炎患者的基于慢性丙基肝炎患者的核心培训疗法（SOF Plus RBV）的实际效力（RWE）和不良事件 - 对8项研究的系统审查和3510名患者
3. Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease [J] . Anna Maruyama, Trana Hussaini, Nilufar Partovi, Canadian Journal of Infectious Diseases and Medical Microbiology: Journal Canadien des Maladies Infectieuses . 2016,第2期

机译：Simeprevir，Sofosbuvir和Ribavirin在HIV合并感染的慢性肾脏病肝移植患者中成功治疗丙型肝炎
4. Successful Treatment of Hepatitis C with Simeprevir Sofosbuvir and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease [O] . Anna Maruyama, Trana Hussaini, Nilufar Partovi, 2016

机译：SimeprevirSofosbuvir和Ribavirin在HIV合并感染的慢性肾脏病肝移植患者中成功治疗丙型肝炎
5. Head-to-head clinical Trial of Sofosbuvir plus Daclatasvir or Simeprevir for 12 weeks in Non-cirrhotic subjects with significant fibrosis infected with chronic Hepatitis C Virus genoType 1 (TNT-1 Study) [O] . H. Pott Junior, G. Bricks, G. Grandi, 2018

机译：Sofosbuvir Plus daclatasvir或Simeprevir的头脑临床试验在非肝硬化受试者中12周，具有慢性丙型肝炎病毒基因型的显着纤维化（TNT-1研究）

Simeprevir and Sofosbuvir With Modified Doses of Ribavirin (RBV) Therapy on Telaprevir-Experienced, Coinfected (With HIV) Cirrhotics With Chronic Hepatitis C (CHC): A Randomized, Open-Label, Clinical Pilot Study, STOP C, Interim Results

著录项

相似文献

相关主题

期刊订阅